Characterization of NWM-1, a novel subclass B3 metallo-β-lactamase found in a clinical isolate of Pseudomonas aeruginosa
Journal of Antimicrobial Chemotherapy · 2025
DOI: 10.1093/jac/dkae428 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Lisa-Marie Höfken und 5 weiteren Autor:innen. Beteiligte Einrichtung: German National Reference Centre for Multidrug-resistant Gram-negative Bacteria, Department of Medical Microbiology, Ruhr-University Bochum, Universi…. Hauptthemen laut MEDLINE: beta-Lactamases, Pseudomonas aeruginosa, Pseudomonas Infections. Die Arbeit nennt 40 Literaturangaben. Gefördert von: German Ministry of Health.
Abstract (Originalsprache)
Objectives
To investigate the carbapenem resistance mechanism of a carbapenem-resistant clinical Pseudomonas aeruginosa isolate.
Methods
A clinical isolate of P. aeruginosa was sent to the German National Reference Centre for multidrug-resistant Gram-negative bacteria for carbapenemase detection. Phenotypic tests for carbapenemase detection and an EDTA-combined disc test were positive, therefore PCR-screenings were done for the most prevalent metallo-β-lactamase (MBL) encoding genes. As no MBL gene could be found, whole-genome sequencing was performed. For characterization, heterologous expression in a E. coli strain with subsequent MIC testing and purification of the new MBL to determine enzyme kinetics with in vitro hydrolysis assays was performed.
Results
WGS revealed the putative gene for a B3 MBL located on the chromosome between several disrupted IS elements with 67% identity to EVM-1, which was named NWM-1. MIC studies and enzyme kinetics confirmed MBL activity. No activity against ceftazidime was observed.
Conclusions
The identification of NWM-1 shows the importance of WGS to identify yet unknown carbapenemases and underlines the diversity of subclass B3 β-lactamases. It also shows that although several carbapenemase variants have already been identified and characterized, there are always new variants to be found in clinical isolates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- German National Reference Centre for Multidrug-resistant Gram-negative Bacteria, Department of Medical Microbiology, Ruhr-University Bochum, Universitätsstraße 150, 44801 Bochum, Germany.
- Landeszentrum Gesundheit Nordrhein-Westfalen, Fachgruppe Infektionsepidemiologie, Bochum, Germany.
- Institut für Medizinische Mikrobiologie, Universitätsklinikum Essen, Essen, Germany.
ORCID-Profile: Sören G Gatermann, Niels Pfennigwerth
Förderung
- German Ministry of Health
Zitieren
APA
Höfken, L. M., Schauer, J., Eisfeld, J., Dziobaka, J., Gatermann, S. G., & Pfennigwerth, N. (2025). Characterization of NWM-1, a novel subclass B3 metallo-β-lactamase found in a clinical isolate of Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkae428
Vancouver
Höfken LM, Schauer J, Eisfeld J, Dziobaka J, Gatermann SG, Pfennigwerth N. Characterization of NWM-1, a novel subclass B3 metallo-β-lactamase found in a clinical isolate of Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkae428
BibTeX
@article{Hfken2025,
author = {Höfken, Lisa-Marie and Schauer, Jennifer and Eisfeld, Jessica and Dziobaka, Jan and Gatermann, Sören G and Pfennigwerth, Niels},
title = {Characterization of NWM-1, a novel subclass B3 metallo-β-lactamase found in a clinical isolate of Pseudomonas aeruginosa},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2025},
doi = {10.1093/jac/dkae428}
}
EUVIMED